Search by Drug Name or NDC

    NDC 65628-0208-10 FIRVANQ Details

    FIRVANQ

    FIRVANQ is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Azurity Pharmaceuticals, Inc. The primary component is .

    Product Information

    NDC 65628-0208
    Product ID 65628-208_0c018d41-1802-4500-e063-6394a90a2ef2
    Associated GPIs 16280080102170
    GCN Sequence Number 009333
    GCN Sequence Number Description vancomycin HCl SOLN RECON 50 MG/ML ORAL
    HIC3 W1J
    HIC3 Description VANCOMYCIN ANTIBIOTICS AND DERIVATIVES
    GCN 41291
    HICL Sequence Number 004042
    HICL Sequence Number Description VANCOMYCIN HCL
    Brand/Generic Brand
    Proprietary Name FIRVANQ
    Proprietary Name Suffix n/a
    Non-Proprietary Name vancomycin hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Azurity Pharmaceuticals, Inc
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208910
    Listing Certified Through 2024-12-31

    Package

    NDC 65628-0208-10 (65628020810)

    NDC Package Code 65628-208-10
    Billing NDC 65628020810
    Package 1 KIT in 1 CARTON (65628-208-10) * 15 g in 1 BOTTLE * 289 mL in 1 BOTTLE
    Marketing Start Date 2018-01-26
    NDC Exclude Flag N
    Pricing Information N/A